ptomatic carotid disease. In a recent meta-analysis
of 36 randomized clinical trials, the efﬁcacy of conventional antiplatelet agents (aspirin; clopidogrel) was
compared with newer agents (cilostazol; triﬂusal). The
major ﬁnding was a trend indicating cilostazol was associated with reduced risk of recurrent stroke compared
with low-dose aspirin þ dipyridamole (OR, 